Table 4.
Practice guideline 2: unresected NSCLC stage IIIA and IIIB Patients
| Item |
Rating percentage
A
|
Mean | SD | Mode | ||
|---|---|---|---|---|---|---|
| Disagree | Neutral | Agree | ||||
|
Assessment of the Recommendations | ||||||
| a. Aware of the recommendations |
10.0 |
2.5 |
87.5 |
6.0 |
1.6 |
7.0 |
| b. Agree with the recommendations |
5.4 |
5.4 |
89.2 |
6.0 |
1.2 |
7.0 |
| c. Recommendations are unambiguous |
5.3 |
7.9 |
86.8 |
5.8 |
1.2 |
6.0 |
| d. Recommendations are supported by the evidence |
5.3 |
2.6 |
92.1 |
5.9 |
1.0 |
6.0 |
| e. Recommendations are current |
2.6 |
10.5 |
86.8 |
5.8 |
1.2 |
6.0 |
| f. Recommendations are easy to apply in their clinical context |
5.3 |
7.9 |
86.8 |
5.8 |
1.3 |
6.0 |
| g. Recommendations are too rigid for the patients they are intended |
76.3 |
5.3 |
18.4 |
2.8 |
1.7 |
2.0 |
| h. Recommendations do not align with how they typically manage these patients |
81.6 |
7.9 |
10.5 |
2.3 |
1.5 |
2.0 |
| i. Recommendations apply to the patients they target |
2.6 |
5.3 |
92.1 |
5.9 |
1.0 |
6.0 |
| j. Recommendations are biased |
89.7 |
10.3 |
0 |
1.8 |
0.9 |
2.0 |
| k. Support for the recommendations |
2.6 |
7.7 |
89.7 |
6.1 |
1.0 |
6.0a |
| l. Clinical practice of respondent aligns with the recommendations |
2.6 |
7.7 |
89.7 |
6.1 |
1.0 |
6.0 |
|
Assessment of the Evidentiary Base | ||||||
| a. It is complete |
5.3 |
13.2 |
81.6 |
5.7 |
1.3 |
6.0 |
| b. It is convincing |
2.6 |
10.5 |
86.8 |
5.7 |
1.2 |
5.0a |
| c. It is informative |
2.6 |
7.9 |
89.5 |
5.9 |
1.2 |
7.0 |
| d. It is relevant to typical patients |
2.6 |
2.6 |
94.7 |
5.9 |
1.1 |
7.0 |
| e. It is strong |
5.4 |
13.5 |
81.1 |
5.5 |
1.3 |
6.0 |
| f. It is current | 5.3 | 18.4 | 76.3 | 5.7 | 1.4 | 7.0 |
NSCLC, non-small cell lung cancer.
a Multiple mode exists. The smallest value is shown.
A Disagree (ratings 1 to 3 on 7-point scale); Neutral (rating 4 on 7-point scale); Agree (rating 5 to 7 on 7-point scale).